Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
Alistair Macdonald, insider at Syneos Health
Alistair Macdonald Insider Alerts

Get notified the next time Alistair Macdonald buys or sells Syneos Health stock. Enter your email address below to get our daily insider buying and selling report.

Alistair Macdonald Insider Information

He joined our Company in 2002 and has served in various senior leadership roles during that time. Prior to his current role, Mr. Macdonald most recently served as our President from January 2015 to October 2016 and as Chief Operating Officer from January 2013 to October 2016. He also served as President, Clinical Development Services from March 2012 to January 2013, Executive Vice President of our Global Oncology Unit from February 2011 to March 2012, Executive Vice President, Strategic Development from October 2009 to February 2011, and Senior Vice President, Biometrics from May 2002 to September 2009.

Mr. Macdonald currently serves on the Board of Directors of the Association of Clinical Research Organizations and Medicines Discovery Catapult, an independent, not-for-profit company, funded by an agency of the UK government. Mr. Macdonald received his Master of Science in Environmental Diagnostics from Cranfield University.

What is Alistair Macdonald's net worth?

The estimated net worth of Alistair Macdonald is at least $19.49 million as of April 9th, 2021. Mr. Macdonald owns 200,470 shares of Syneos Health stock worth more than $19,491,698 as of December 5th. This net worth approximation does not reflect any other assets that Mr. Macdonald may own. Learn More.

How do I contact Alistair Macdonald?

The corporate mailing address for Mr. Macdonald and other Syneos Health executives is 1030 Sync Street, Morrisville NC, 27560. Syneos Health can also be reached via phone at (919) 876-9300 and via email at [email protected]

Has Alistair Macdonald been buying or selling shares of Syneos Health?

Alistair Macdonald has not been actively trading shares of Syneos Health during the last ninety days. Most recently, Alistair Macdonald sold 35,553 shares of the business's stock in a transaction on Tuesday, August 3rd. The shares were sold at an average price of $87.96, for a transaction totalling $3,127,241.88.

Who are Syneos Health's active insiders?

Syneos Health's insider roster includes Donna Kralowetz (CAO), Alistair Macdonald (CEO), John Maldonado (Director), Jason Meggs (CFO), and Matthew Monaghan (Director).

Are insiders buying or selling shares of Syneos Health?

During the last twelve months, insiders at the sold shares 28 times. They sold a total of 15,652,189 shares worth more than $1,245,885,776.75. The most recent insider tranaction occured on September, 3rd when CFO Jason M Meggs sold 9,223 shares worth more than $876,185.00. Insiders at Syneos Health own 0.3 % of the company.

Information on this page was last updated on 9/3/2021.

Alistair Macdonald Insider Trading History at Syneos Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/3/2021Sell35,553$87.96$3,127,241.88View SEC Filing Icon  
4/9/2021Sell14,039$80.00$1,123,120.00200,470View SEC Filing Icon  
4/1/2021Sell17,398$77.61$1,350,258.78231,907View SEC Filing Icon  
2/2/2021Sell64,497$75.71$4,883,067.87
12/22/2020Sell1,200$70.02$84,024.00245,487View SEC Filing Icon  
8/3/2020Sell10,289$65.07$669,505.23
7/14/2020Sell5,173$58.68$303,551.64264,809View SEC Filing Icon  
2/13/2019Sell8,143$53.00$431,579.00View SEC Filing Icon  
2/5/2019Sell6,697$53.04$355,208.88View SEC Filing Icon  
9/18/2017Sell2,348$54.60$128,200.8099,453View SEC Filing Icon  
8/17/2017Sell8,828$55.65$491,278.20110,629View SEC Filing Icon  
7/3/2017Sell10,555$58.38$616,200.9083,935View SEC Filing Icon  
5/1/2017Sell9,467$45.00$426,015.0083,935View SEC Filing Icon  
3/3/2017Sell8,828$45.00$397,260.0083,296View SEC Filing Icon  
1/20/2017Sell1,375$50.50$69,437.5052,854View SEC Filing Icon  
1/5/2017Sell14,840$52.19$774,499.6069,069View SEC Filing Icon  
8/17/2016Sell8,828$43.80$386,666.4063,057View SEC Filing Icon  
7/11/2016Sell9,468$40.19$380,518.9228,144View SEC Filing Icon  
12/31/2015Sell159,599$47.46$7,574,568.548,699View SEC Filing Icon  
12/7/2015Sell42,959$44.63$1,917,260.1755,681View SEC Filing Icon  
9/28/2015Sell44,522$39.93$1,777,763.4655,681View SEC Filing Icon  
See Full Table

Alistair Macdonald Buying and Selling Activity at Syneos Health

This chart shows Alistair Macdonald's buying and selling at Syneos Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Syneos Health Company Overview

Syneos Health logo
Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded in 1998 and is headquartered in Morrisville, NC.
Read More

Today's Range

Now: $97.23
Low: $96.21
High: $99.40

50 Day Range

MA: $93.98
Low: $86.01
High: $102.89

2 Week Range

Now: $97.23
Low: $62.62
High: $104.18

Volume

385,198 shs

Average Volume

849,471 shs

Market Capitalization

$10.08 billion

P/E Ratio

40.68

Dividend Yield

N/A

Beta

1.78
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!